vs
MidWestOne Financial Group, Inc.（MOFG）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
MidWestOne Financial Group, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.7倍（$61.3M vs $35.5M），MidWestOne Financial Group, Inc.净利率更高（27.8% vs -304.2%，领先332.0%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 35.9%），MidWestOne Financial Group, Inc.自由现金流更多（$16.7M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 37.2%）
中西部一号金融集团是一家银行控股公司，总部位于美国爱荷华城。集团旗下共运营56家分行，是总部设于爱荷华州的第三大银行，业务覆盖爱荷华州、明尼苏达州、威斯康星州、科罗拉多州以及佛罗里达州。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
MOFG vs RXRX — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $61.3M | $35.5M |
| 净利润 | $17.0M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 35.1% | -304.8% |
| 净利率 | 27.8% | -304.2% |
| 营收同比 | 35.9% | 681.7% |
| 净利润同比 | 117.8% | 39.6% |
| 每股收益（稀释后） | $0.82 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $35.5M | ||
| Q3 25 | $61.3M | $5.2M | ||
| Q2 25 | $60.2M | $19.2M | ||
| Q1 25 | $57.6M | $14.7M | ||
| Q4 24 | $48.9M | $4.5M | ||
| Q3 24 | $37.5M | $26.1M | ||
| Q2 24 | $57.9M | $14.4M | ||
| Q1 24 | $44.5M | $13.8M |
| Q4 25 | — | $-108.1M | ||
| Q3 25 | $17.0M | $-162.3M | ||
| Q2 25 | $10.0M | $-171.9M | ||
| Q1 25 | $15.1M | $-202.5M | ||
| Q4 24 | $16.3M | $-178.9M | ||
| Q3 24 | $-95.7M | $-95.8M | ||
| Q2 24 | $15.8M | $-97.5M | ||
| Q1 24 | $3.3M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | — | -304.8% | ||
| Q3 25 | 35.1% | -3327.6% | ||
| Q2 25 | 20.9% | -916.8% | ||
| Q1 25 | 34.0% | -1297.9% | ||
| Q4 24 | 43.1% | -4042.4% | ||
| Q3 24 | -347.0% | -377.1% | ||
| Q2 24 | 36.0% | -697.4% | ||
| Q1 24 | 9.5% | -698.4% |
| Q4 25 | — | -304.2% | ||
| Q3 25 | 27.8% | -3135.3% | ||
| Q2 25 | 16.6% | -894.2% | ||
| Q1 25 | 26.3% | -1373.3% | ||
| Q4 24 | 33.4% | -3935.5% | ||
| Q3 24 | -255.1% | -367.5% | ||
| Q2 24 | 27.3% | -676.6% | ||
| Q1 24 | 7.3% | -662.4% |
| Q4 25 | — | $-0.17 | ||
| Q3 25 | $0.82 | $-0.36 | ||
| Q2 25 | $0.48 | $-0.41 | ||
| Q1 25 | $0.73 | $-0.50 | ||
| Q4 24 | $1.30 | $-0.56 | ||
| Q3 24 | $-6.05 | $-0.34 | ||
| Q2 24 | $1.00 | $-0.40 | ||
| Q1 24 | $0.21 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $743.3M |
| 总债务越低越好 | $98.0M | $9.6M |
| 股东权益账面价值 | $606.1M | $1.1B |
| 总资产 | $6.2B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.16× | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | — | $743.3M | ||
| Q3 25 | — | $659.8M | ||
| Q2 25 | — | $525.1M | ||
| Q1 25 | — | $500.5M | ||
| Q4 24 | — | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | — | $474.3M | ||
| Q1 24 | — | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | $98.0M | $11.9M | ||
| Q2 25 | $112.3M | $14.2M | ||
| Q1 25 | $111.4M | $16.4M | ||
| Q4 24 | $113.4M | $19.0M | ||
| Q3 24 | $115.1M | $20.5M | ||
| Q2 24 | $114.8M | $22.9M | ||
| Q1 24 | $122.1M | — |
| Q4 25 | — | $1.1B | ||
| Q3 25 | $606.1M | $1.0B | ||
| Q2 25 | $589.0M | $919.1M | ||
| Q1 25 | $579.6M | $933.9M | ||
| Q4 24 | $559.7M | $1.0B | ||
| Q3 24 | $562.2M | $524.6M | ||
| Q2 24 | $543.3M | $584.4M | ||
| Q1 24 | $528.0M | $401.2M |
| Q4 25 | — | $1.5B | ||
| Q3 25 | $6.2B | $1.4B | ||
| Q2 25 | $6.2B | $1.3B | ||
| Q1 25 | $6.3B | $1.3B | ||
| Q4 24 | $6.2B | $1.4B | ||
| Q3 24 | $6.6B | $726.5M | ||
| Q2 24 | $6.6B | $775.9M | ||
| Q1 24 | $6.7B | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | 0.16× | 0.01× | ||
| Q2 25 | 0.19× | 0.02× | ||
| Q1 25 | 0.19× | 0.02× | ||
| Q4 24 | 0.20× | 0.02× | ||
| Q3 24 | 0.20× | 0.04× | ||
| Q2 24 | 0.21× | 0.04× | ||
| Q1 24 | 0.23× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.7M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $16.7M | $-47.3M |
| 自由现金流率自由现金流/营收 | 27.3% | -133.1% |
| 资本支出强度资本支出/营收 | 1.5% | 3.5% |
| 现金转化率经营现金流/净利润 | 1.04× | — |
| 过去12个月自由现金流最近4个季度 | $109.6M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | — | $-46.1M | ||
| Q3 25 | $17.7M | $-117.4M | ||
| Q2 25 | $24.9M | $-76.4M | ||
| Q1 25 | $8.7M | $-132.0M | ||
| Q4 24 | $63.2M | $-115.4M | ||
| Q3 24 | $-2.8M | $-59.2M | ||
| Q2 24 | $25.2M | $-82.2M | ||
| Q1 24 | $9.6M | $-102.3M |
| Q4 25 | — | $-47.3M | ||
| Q3 25 | $16.7M | $-117.6M | ||
| Q2 25 | $23.8M | $-79.6M | ||
| Q1 25 | $8.3M | $-133.8M | ||
| Q4 24 | $60.8M | $-116.7M | ||
| Q3 24 | $-3.0M | $-63.8M | ||
| Q2 24 | $24.6M | $-83.4M | ||
| Q1 24 | $9.1M | $-109.0M |
| Q4 25 | — | -133.1% | ||
| Q3 25 | 27.3% | -2272.5% | ||
| Q2 25 | 39.5% | -413.9% | ||
| Q1 25 | 14.4% | -907.4% | ||
| Q4 24 | 124.2% | -2567.7% | ||
| Q3 24 | -7.9% | -244.6% | ||
| Q2 24 | 42.5% | -578.5% | ||
| Q1 24 | 20.4% | -789.9% |
| Q4 25 | — | 3.5% | ||
| Q3 25 | 1.5% | 4.7% | ||
| Q2 25 | 1.9% | 16.4% | ||
| Q1 25 | 0.7% | 12.4% | ||
| Q4 24 | 4.9% | 28.6% | ||
| Q3 24 | 0.6% | 17.5% | ||
| Q2 24 | 1.1% | 8.2% | ||
| Q1 24 | 1.2% | 48.2% |
| Q4 25 | — | — | ||
| Q3 25 | 1.04× | — | ||
| Q2 25 | 2.50× | — | ||
| Q1 25 | 0.57× | — | ||
| Q4 24 | 3.87× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.60× | — | ||
| Q1 24 | 2.93× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
